Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease

Manchia, Mirko

First

Writing - Original Draft Preparation

;Squassina, Alessio

Second

Writing - Original Draft Preparation

;Pisanu, Claudia;Congiu, Donatella;Garzilli, Mario;Guiso, Beatrice;Suprani, Federico;Paribello, Pasquale;Pulcinelli, Vittoria;Iaselli, Maria Novella;Pinna, Federica;Valtorta, Flavia;Carpiniello, Bernardo

Penultimate

Supervision

;Comai, Stefano

Last

Supervision

2019-01-01

---

Abstract

Bipolar disorder (BD) is characterized by recurrent episodes of depression and mania/hypomania alternating with intervals of well-being. The neurobiological underpinnings of BD are still veiled although there is evidence pointing to a malfunction of the circadian clock system that is regulated by the neuromodulator melatonin (MLT). Small sample size studies in BD patients have shown that changes in the levels of MLT are associated with shifts in illness status. Moreover, mood stabilizers (including lithium and valproic acid) influence the MLT system. Of interest, MLT also modulates intestinal microbiota, and recent work suggests an important role of microbiota alterations in neuropsychiatric disorders, including BD. This study is designed to explore whether the possible patterns of associations between changes in the levels of MLT and its precursors and BD mood phases are modulated by variants within the genes encoding for the elements of the MLT system and/or by the microbiota composition.